# Cipla Ltd., Bangalore, India – FDA Inspections

Source: https://www.keypedia.com/companies/cipla-ltd/d90a952b-3052-4e33-9969-5db3f2bbae82

> Inspection records and compliance data for Cipla Ltd. in Bangalore. 4 FDA inspections on record, 1 Form 483, last inspected May 30, 2025.

---

## Details

- Name: Cipla Ltd.
- FEI Number: 3005857289
- Business Operations: API MANUFACTURE
- Address Line 1: 285, 286 and 287, KIADB, IV Phase, Bommasandra-Jigani Link Road
- City: Bangalore
- Country Name: India
- Address: 285, 286 and 287, KIADB, IV Phase, Bommasandra-Jigani Link Road, Bangalore, India
- Country: India

## Related Documents

- [483 - Cipla Ltd. - Unknown Date](https://www.keypedia.com/records/483/cipla-ltd/3f8962ce-3c66-4db6-96ea-a709462fa3a3) — source: FDA, date: Invalid Date
- [FDA Inspection 1271320 - Cipla Ltd. - 2025-05-30](https://www.keypedia.com/records/fda_inspections/cipla-ltd/07e0b1bd-cab9-4422-8834-b1e0ebb55d3e) — source: FDA, date: May 30, 2025
- FDA Inspection 1271320 - Cipla Ltd. - 2025-05-30 — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 30, 2025
- [483 - Cipla Ltd. - 2025-05-26](https://www.keypedia.com/records/483/cipla-ltd/1e5d4e6e-c770-4dc1-bfc6-14c2d583e30c) — source: FDA, date: May 26, 2025
- FDA Inspection 1117627 - Cipla Ltd. - 2020-01-24 — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 24, 2020
- [483 - Cipla Ltd. - 2020-01-20](https://www.keypedia.com/records/483/cipla-ltd/188882e0-4d67-4abb-bd52-e0728ee71ad4) — source: FDA, date: January 20, 2020
- FDA Inspection 921236 - Cipla Ltd. - 2015-03-12 — classification: No Action Indicated (NAI), source: FDA, date: March 12, 2015
- [FDA Inspection 768491 - Cipla Ltd. - 2011-11-17](https://www.keypedia.com/records/fda_inspections/cipla-ltd/6f02ef12-1475-47c2-a395-592976ffb865) — classification: No Action Indicated (NAI), source: FDA, date: November 17, 2011

## Related Companies

- [Ercros S.A.](https://www.keypedia.com/companies/ercros-sa/adeb63ee-2821-47de-939a-39c363e39854)
- [GlaxoSmithKline dba Human Genome Sciences Inc](https://www.keypedia.com/companies/glaxosmithkline-dba-human-genome-sciences-inc/c3dd2e54-125d-4d56-b0dc-18cb333074cc)
- [SpecGx LLC](https://www.keypedia.com/companies/specgx-llc/715bb75a-8d3a-4469-9e6d-f617c2f39c93)
- [ImClone Systems, LLC](https://www.keypedia.com/companies/imclone-systems-llc/ccde4edf-e0cb-4367-a935-725ce0bad4d3)
- [Biocon Biosphere Limited](https://www.keypedia.com/companies/biocon-biosphere-limited/4c5f824e-c399-4c0e-91be-45739741dc2c)
- [Biocon Limited](https://www.keypedia.com/companies/biocon-limited/7b8920c7-f5be-4f17-8100-3bede3943790)
- [MSN Laboratories Private Limited, Unit-II](https://www.keypedia.com/companies/msn-laboratories-private-limited-unit-ii/539d7af5-94e6-4abe-b01b-fa911be84d2a)
- [Agilent Technologies Inc](https://www.keypedia.com/companies/agilent-technologies-inc/865fe026-9db0-4e3e-bc4a-e0d25b465093)
- [Organo Sintesis, S.A. De C.V.](https://www.keypedia.com/companies/organo-sintesis-sa-de-cv/0d8f4d8d-0fbd-4c4a-8362-439c74e4f37d)
- [Curia India Private Limited](https://www.keypedia.com/companies/curia-india-private-limited/957a813a-fe8f-4ea0-92bb-b16a25119979)

## Related Officers

- [Chemist/Investigator - Pharmaceutical Quality](https://www.keypedia.com/people/walden-h-lee/18131eea-d1cb-47c4-af79-bea22d436031)
- [Teresa I. Navas](https://www.keypedia.com/people/teresa-i-navas/43f747c0-18c2-4630-bab9-936204aa93aa)
- [Investigator](https://www.keypedia.com/people/roger-f-zabinski/87e05838-f8b5-489a-8db7-6669e68a2c2e)
- [Mr. Aron Shapiro](https://www.keypedia.com/people/mr-aron-shapiro/4e7e6c39-4aa7-4cdc-8a62-620b3479374c)
